<p>中东股市近期出现了混合走势，沙特股市因获利回吐而下跌，而卡塔尔指数则小幅上涨，反映出地区经济的持续变化。尽管它们给人一种复古的感觉，便士股票仍然是对那些对小型或新兴公司感兴趣的投资者来说一个相关的投资领域。这些股票在强劲的财务支持下，能够提供可负担性和潜在的增长，使其成为寻求低调机会的投资者的有趣选择。</p>
<h3>中东地区十大便士股票</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>股价</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益与风险</strong></td>
</tr>
<tr>
<td>Maharah for Human Resources (SASE:1831)</td>
<td>SAR4.71</td>
<td>SAR2.11B</td>
<td>✅ 2 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Thob Al Aseel (SASE:4012)</td>
<td>SAR3.69</td>
<td>SAR1.48B</td>
<td>✅ 2 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>Alarum Technologies (TASE:ALAR)</td>
<td>₪4.835</td>
<td>₪344.3M</td>
<td>✅ 3 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>E7 Group PJSC (ADX:E7)</td>
<td>AED1.04</td>
<td>AED2.1B</td>
<td>✅ 5 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Al Wathba National Insurance Company PJSC (ADX:AWNIC)</td>
<td>AED3.30</td>
<td>AED683.1M</td>
<td>✅ 2 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Dubai National Insurance &amp; Reinsurance (P.S.C.) (DFM:DNIR)</td>
<td>AED3.30</td>
<td>AED381.15M</td>
<td>✅ 2 ⚠️ 4 查看分析</td>
</tr>
<tr>
<td>Dubai Investments PJSC (DFM:DIC)</td>
<td>AED3.08</td>
<td>AED13.05B</td>
<td>✅ 2 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Al Dhafra Insurance Company P.S.C (ADX:DHAFRA)</td>
<td>AED4.86</td>
<td>AED486M</td>
<td>✅ 1 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC)</td>
<td>AED0.82</td>
<td>AED503.63M</td>
<td>✅ 2 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>Tgi Infrastructures (TASE:TGI)</td>
<td>₪2.705</td>
<td>₪212.34M</td>
<td>✅ 2 ⚠️ 3 查看分析</td>
</tr>
</tbody>
</table>
<p>点击这里查看我们中东便士股票筛选器的 79 只股票的完整列表。</p>
<p>下面我们展示了一些经过筛选的股票。</p>
<h2>乌姆盖万国家银行 (PSC) (ADX:NBQ)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> 乌姆盖万国家银行 (PSC) 在阿联酋提供零售和企业银行服务，市值为 AED5.38 亿。</p>
<p><strong>运营：</strong> 银行的收入主要来自国库和投资，贡献 AED410.1 百万，以及零售和企业银行，增加 AED342.24 百万。</p>
<p><strong>市值：</strong> AED5.38B</p>
<p>乌姆盖万国家银行 (PSC) 以 AED5.38 亿的稳健市值脱颖而出，主要得益于国库和投资的可观收入，以及零售和企业银行。尽管每周波动率稳定在 5%，但该银行的盈利增长在过去一年中减速至 0.3%，低于其五年平均水平 19.8%。该银行的贷款与存款比率适中，为 63%，但面临 2.2% 的高不良贷款挑战。其市盈率为 10.1 倍，尽管股本回报率仍然较低，为 8.6%。</p>
<ul>
<li>点击这里了解乌姆盖万国家银行 (PSC) 的细微差别，查看我们的详细分析财务健康报告。</li>
<li>在这里了解乌姆盖万国家银行 (PSC) 的历史表现。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b01d9b94-4ba6-4452-b10b-790b7e5998af/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b01d9b94-4ba6-4452-b10b-790b7e5998af/chart/financial-position-analysis"/></p>
<p>ADX:NBQ 财务状况分析截至 2025 年 9 月</p>
<h2>InterCure (TASE:INCR)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> InterCure Ltd. 从事医用大麻及大麻基产品的研究、种植、生产、营销和分销，业务覆盖以色列及国际市场，市值为 ₪235.67 百万。</p>
<p><strong>运营：</strong> 该公司的收入主要来自其大麻业务，贡献 ₪238.85 百万。</p>
<p><strong>市值：</strong> ₪235.67M</p>
<p>InterCure Ltd. 的市值为 ₪235.67 百万，主要来自其大麻业务，总收入为 ₪238.85 百万。尽管公司处于亏损状态，股本回报率为负 18.3%，但其短期资产为 ₪391.8 百万，超过其短期和长期负债，显示出强劲的流动性。公司的债务与股本比率在五年内有所上升，但仍保持在 26.3% 的满意水平。InterCure 的董事会经验丰富，平均任期为七年；然而，由于缺乏任期长度的数据，管理团队的经验尚不明确。</p>
<ul>
<li>点击这里深入了解 InterCure 的具体情况，查看我们的详细资产负债表健康报告。</li>
<li>通过我们的详细历史表现报告评估 InterCure 的过去业绩。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/e639da53-20ca-43ad-bcf7-9318fe606b2c/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/e639da53-20ca-43ad-bcf7-9318fe606b2c/chart/debt-equity-history-analysis"/></p>
<p>TASE:INCR 债务与股本历史及分析截至 2025 年 9 月</p>
<h2>SavorEat (TASE:SVRT-M)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> SavorEat Ltd. 是一家开发基于纤维素的肉类替代品的公司，旨在模拟真实肉类的食用体验，市值为 ₪5.35 百万。</p>
<p><strong>运营：</strong> SavorEat Ltd. 尚未报告任何收入细分。</p>
<p><strong>市值：</strong> ₪5.35M</p>
<p>SavorEat Ltd. 的市值为 ₪5.35 百万，仍处于无收入和亏损状态，2025 年上半年报告净亏损 ILS 4.92 百万。尽管没有债务且董事会经验丰富，平均任期为 5.6 年，但由于其股价高度波动以及基于当前自由现金流趋势的现金流不足一年，公司面临财务挑战。短期资产（₪6.2M）超过负债（₪840K），提供了一定的流动性缓冲，但盈利能力仍然难以实现，五年来亏损年均增长 2.5%。</p>
<ul>
<li>点击这里访问我们的完整财务健康分析报告，以了解 SavorEat 的动态。</li>
<li>通过查看我们的历史表现报告，获取 SavorEat 的历史结果的见解。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/035f9675-2f76-4849-93b9-566b1416b415/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/035f9675-2f76-4849-93b9-566b1416b415/chart/financial-position-analysis"/></p>
<p>截至 2025 年 9 月的 TASE:SVRT-M 财务状况分析</p>
<h2>将想法转化为行动</h2>
<ul>
<li>点击这里访问我们 79 只中东便士股票的完整索引。</li>
<li>对其他选择感到好奇？人工智能即将改变医疗保健。这 31 只股票正在从早期诊断到药物发现的各个方面进行研发。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前投资。</li>
</ul>
<p><em>这篇文章由 Simply Wall St 撰写，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，采用无偏见的方法，我们的文章并不构成财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>

INCR

ALAR

<p>中东股市正经历混合走势，沙特因获利了结而出现下跌，而卡塔尔的指数则上涨。被忽视的低价股提供了负担得起的投资机会，具有潜在的增长空间。值得关注的股票包括 Maharah 人力资源公司、Thob Al Aseel 和 Alarum Technologies 等。乌姆阿尔凯温国家银行显示出稳健的市值，但面临不良贷款的挑战。InterCure 在大麻行业运营，但尚未盈利，而专注于肉类替代品的 SavorEat 则处于无收入状态，并面临财务困难。投资者被鼓励探索这些不被关注的投资选项</p>

<p>The Middle Eastern stock markets have recently experienced mixed movements, with the Saudi bourse seeing losses due to profit-taking while Qatar's index has edged higher, reflecting ongoing regional economic shifts. Despite their vintage feel, penny stocks remain a relevant investment area for those interested in smaller or newer companies. These stocks can offer affordability and potential growth when backed by strong financials, making them intriguing options for investors seeking under-the-radar opportunities.</p>
<div class="lb-trans"><p>中东股市近期出现了混合走势，沙特股市因获利回吐而下跌，而卡塔尔指数则小幅上涨，反映出地区经济的持续变化。尽管它们给人一种复古的感觉，便士股票仍然是对那些对小型或新兴公司感兴趣的投资者来说一个相关的投资领域。这些股票在强劲的财务支持下，能够提供可负担性和潜在的增长，使其成为寻求低调机会的投资者的有趣选择。</p>
</div><h3>Top 10 Penny Stocks In The Middle East</h3>
<div class="lb-trans"><h3>中东地区十大便士股票</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Share Price</strong></td>
<td><strong>Market Cap</strong></td>
<td><strong>Rewards &amp; Risks</strong></td>
</tr>
<tr>
<td>Maharah for Human Resources (SASE:1831)</td>
<td>SAR4.71</td>
<td>SAR2.11B</td>
<td>✅ 2 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Thob Al Aseel (SASE:4012)</td>
<td>SAR3.69</td>
<td>SAR1.48B</td>
<td>✅ 2 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Alarum Technologies (TASE:ALAR)</td>
<td>₪4.835</td>
<td>₪344.3M</td>
<td>✅ 3 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>E7 Group PJSC (ADX:E7)</td>
<td>AED1.04</td>
<td>AED2.1B</td>
<td>✅ 5 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Al Wathba National Insurance Company PJSC (ADX:AWNIC)</td>
<td>AED3.30</td>
<td>AED683.1M</td>
<td>✅ 2 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Dubai National Insurance &amp; Reinsurance (P.S.C.) (DFM:DNIR)</td>
<td>AED3.30</td>
<td>AED381.15M</td>
<td>✅ 2 ⚠️ 4 View Analysis &gt;</td>
</tr>
<tr>
<td>Dubai Investments PJSC (DFM:DIC)</td>
<td>AED3.08</td>
<td>AED13.05B</td>
<td>✅ 2 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Al Dhafra Insurance Company P.S.C (ADX:DHAFRA)</td>
<td>AED4.86</td>
<td>AED486M</td>
<td>✅ 1 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC)</td>
<td>AED0.82</td>
<td>AED503.63M</td>
<td>✅ 2 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Tgi Infrastructures (TASE:TGI)</td>
<td>₪2.705</td>
<td>₪212.34M</td>
<td>✅ 2 ⚠️ 3 View Analysis &gt;</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>股价</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益与风险</strong></td>
</tr>
<tr>
<td>Maharah for Human Resources (SASE:1831)</td>
<td>SAR4.71</td>
<td>SAR2.11B</td>
<td>✅ 2 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Thob Al Aseel (SASE:4012)</td>
<td>SAR3.69</td>
<td>SAR1.48B</td>
<td>✅ 2 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>Alarum Technologies (TASE:ALAR)</td>
<td>₪4.835</td>
<td>₪344.3M</td>
<td>✅ 3 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>E7 Group PJSC (ADX:E7)</td>
<td>AED1.04</td>
<td>AED2.1B</td>
<td>✅ 5 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Al Wathba National Insurance Company PJSC (ADX:AWNIC)</td>
<td>AED3.30</td>
<td>AED683.1M</td>
<td>✅ 2 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Dubai National Insurance &amp; Reinsurance (P.S.C.) (DFM:DNIR)</td>
<td>AED3.30</td>
<td>AED381.15M</td>
<td>✅ 2 ⚠️ 4 查看分析</td>
</tr>
<tr>
<td>Dubai Investments PJSC (DFM:DIC)</td>
<td>AED3.08</td>
<td>AED13.05B</td>
<td>✅ 2 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Al Dhafra Insurance Company P.S.C (ADX:DHAFRA)</td>
<td>AED4.86</td>
<td>AED486M</td>
<td>✅ 1 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC)</td>
<td>AED0.82</td>
<td>AED503.63M</td>
<td>✅ 2 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>Tgi Infrastructures (TASE:TGI)</td>
<td>₪2.705</td>
<td>₪212.34M</td>
<td>✅ 2 ⚠️ 3 查看分析</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 79 stocks from our Middle Eastern Penny Stocks screener.</p>
<div class="lb-trans"><p>点击这里查看我们中东便士股票筛选器的 79 只股票的完整列表。</p>
</div><p>Underneath we present a selection of stocks filtered out by our screen.</p>
<div class="lb-trans"><p>下面我们展示了一些经过筛选的股票。</p>
</div><h2>National Bank of Umm Al-Qaiwain (PSC) (ADX:NBQ)</h2>
<div class="lb-trans"><h2>乌姆盖万国家银行 (PSC) (ADX:NBQ)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> National Bank of Umm Al-Qaiwain (PSC) provides retail and corporate banking services in the United Arab Emirates, with a market capitalization of AED5.38 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 乌姆盖万国家银行 (PSC) 在阿联酋提供零售和企业银行服务，市值为 AED5.38 亿。</p>
</div><p><strong>Operations:</strong> The bank's revenue is primarily derived from Treasury and Investments, contributing AED410.1 million, and Retail and Corporate Banking, which adds AED342.24 million.</p>
<div class="lb-trans"><p><strong>运营：</strong> 银行的收入主要来自国库和投资，贡献 AED410.1 百万，以及零售和企业银行，增加 AED342.24 百万。</p>
</div><p><strong>Market Cap:</strong> AED5.38B</p>
<div class="lb-trans"><p><strong>市值：</strong> AED5.38B</p>
</div><p>National Bank of Umm Al-Qaiwain (PSC) stands out with a solid market capitalization of AED5.38 billion, driven by substantial revenue from Treasury and Investments, as well as Retail and Corporate Banking. Despite a stable weekly volatility at 5%, the bank's earnings growth has decelerated to 0.3% over the past year, trailing behind its five-year average of 19.8%. The bank maintains an appropriate Loans to Deposits ratio at 63% but faces challenges with high bad loans at 2.2%. Its Price-To-Earnings ratio is competitive at 10.1x, though Return on Equity remains low at 8.6%.</p>
<div class="lb-trans"><p>乌姆盖万国家银行 (PSC) 以 AED5.38 亿的稳健市值脱颖而出，主要得益于国库和投资的可观收入，以及零售和企业银行。尽管每周波动率稳定在 5%，但该银行的盈利增长在过去一年中减速至 0.3%，低于其五年平均水平 19.8%。该银行的贷款与存款比率适中，为 63%，但面临 2.2% 的高不良贷款挑战。其市盈率为 10.1 倍，尽管股本回报率仍然较低，为 8.6%。</p>
</div><ul>
<li>Click here to discover the nuances of National Bank of Umm Al-Qaiwain (PSC) with our detailed analytical financial health report.</li>
<li>Learn about National Bank of Umm Al-Qaiwain (PSC)'s historical performance here.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里了解乌姆盖万国家银行 (PSC) 的细微差别，查看我们的详细分析财务健康报告。</li>
<li>在这里了解乌姆盖万国家银行 (PSC) 的历史表现。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b01d9b94-4ba6-4452-b10b-790b7e5998af/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/b01d9b94-4ba6-4452-b10b-790b7e5998af/chart/financial-position-analysis"/></p>
<p>ADX:NBQ Financial Position Analysis as at Sep 2025</p>
<div class="lb-trans"><p>ADX:NBQ 财务状况分析截至 2025 年 9 月</p>
</div><h2>InterCure (TASE:INCR)</h2>
<div class="lb-trans"><h2>InterCure (TASE:INCR)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> InterCure Ltd. operates in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use both in Israel and internationally, with a market cap of ₪235.67 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> InterCure Ltd. 从事医用大麻及大麻基产品的研究、种植、生产、营销和分销，业务覆盖以色列及国际市场，市值为 ₪235.67 百万。</p>
</div><p><strong>Operations:</strong> The company generates revenue primarily from its cannabis segment, which accounted for ₪238.85 million.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司的收入主要来自其大麻业务，贡献 ₪238.85 百万。</p>
</div><p><strong>Market Cap:</strong> ₪235.67M</p>
<div class="lb-trans"><p><strong>市值：</strong> ₪235.67M</p>
</div><p>InterCure Ltd., with a market cap of ₪235.67 million, primarily generates revenue from its cannabis segment, totaling ₪238.85 million. Despite being unprofitable with a negative Return on Equity of -18.3%, the company maintains short-term assets of ₪391.8 million that exceed both its short and long-term liabilities, indicating a strong liquidity position. The company's debt to equity ratio has increased over five years but remains satisfactory at 26.3%. InterCure's board is experienced with an average tenure of seven years; however, the management team's experience is unclear due to insufficient data on tenure lengths.</p>
<div class="lb-trans"><p>InterCure Ltd. 的市值为 ₪235.67 百万，主要来自其大麻业务，总收入为 ₪238.85 百万。尽管公司处于亏损状态，股本回报率为负 18.3%，但其短期资产为 ₪391.8 百万，超过其短期和长期负债，显示出强劲的流动性。公司的债务与股本比率在五年内有所上升，但仍保持在 26.3% 的满意水平。InterCure 的董事会经验丰富，平均任期为七年；然而，由于缺乏任期长度的数据，管理团队的经验尚不明确。</p>
</div><ul>
<li>Dive into the specifics of InterCure here with our thorough balance sheet health report.</li>
<li>Assess InterCure's previous results with our detailed historical performance reports.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里深入了解 InterCure 的具体情况，查看我们的详细资产负债表健康报告。</li>
<li>通过我们的详细历史表现报告评估 InterCure 的过去业绩。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/e639da53-20ca-43ad-bcf7-9318fe606b2c/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/e639da53-20ca-43ad-bcf7-9318fe606b2c/chart/debt-equity-history-analysis"/></p>
<p>TASE:INCR Debt to Equity History and Analysis as at Sep 2025</p>
<div class="lb-trans"><p>TASE:INCR 债务与股本历史及分析截至 2025 年 9 月</p>
</div><h2>SavorEat (TASE:SVRT-M)</h2>
<div class="lb-trans"><h2>SavorEat (TASE:SVRT-M)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> SavorEat Ltd. is a company that develops cellulose-based meat substitutes designed to mimic the eating experience of real meat, with a market cap of ₪5.35 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> SavorEat Ltd. 是一家开发基于纤维素的肉类替代品的公司，旨在模拟真实肉类的食用体验，市值为 ₪5.35 百万。</p>
</div><p><strong>Operations:</strong> No revenue segments have been reported for SavorEat Ltd.</p>
<div class="lb-trans"><p><strong>运营：</strong> SavorEat Ltd. 尚未报告任何收入细分。</p>
</div><p><strong>Market Cap:</strong> ₪5.35M</p>
<div class="lb-trans"><p><strong>市值：</strong> ₪5.35M</p>
</div><p>SavorEat Ltd., with a market cap of ₪5.35 million, remains pre-revenue and unprofitable, reporting a net loss of ILS 4.92 million for the first half of 2025. Despite having no debt and an experienced board with an average tenure of 5.6 years, the company faces financial challenges due to its highly volatile share price and less than one year of cash runway based on current free cash flow trends. Short-term assets (₪6.2M) exceed liabilities (₪840K), providing some liquidity cushion, though profitability remains elusive as losses have increased by 2.5% annually over five years.</p>
<div class="lb-trans"><p>SavorEat Ltd. 的市值为 ₪5.35 百万，仍处于无收入和亏损状态，2025 年上半年报告净亏损 ILS 4.92 百万。尽管没有债务且董事会经验丰富，平均任期为 5.6 年，但由于其股价高度波动以及基于当前自由现金流趋势的现金流不足一年，公司面临财务挑战。短期资产（₪6.2M）超过负债（₪840K），提供了一定的流动性缓冲，但盈利能力仍然难以实现，五年来亏损年均增长 2.5%。</p>
</div><ul>
<li>Click here and access our complete financial health analysis report to understand the dynamics of SavorEat.</li>
<li>Gain insights into SavorEat's historical outcomes by reviewing our past performance report.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里访问我们的完整财务健康分析报告，以了解 SavorEat 的动态。</li>
<li>通过查看我们的历史表现报告，获取 SavorEat 的历史结果的见解。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/035f9675-2f76-4849-93b9-566b1416b415/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/035f9675-2f76-4849-93b9-566b1416b415/chart/financial-position-analysis"/></p>
<p>TASE:SVRT-M Financial Position Analysis as at Sep 2025</p>
<div class="lb-trans"><p>截至 2025 年 9 月的 TASE:SVRT-M 财务状况分析</p>
</div><h2>Turning Ideas Into Actions</h2>
<div class="lb-trans"><h2>将想法转化为行动</h2>
</div><ul>
<li>Click here to access our complete index of 79 Middle Eastern Penny Stocks.</li>
<li>Curious About Other Options? AI is about to change healthcare. These 31 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里访问我们 79 只中东便士股票的完整索引。</li>
<li>对其他选择感到好奇？人工智能即将改变医疗保健。这 31 只股票正在从早期诊断到药物发现的各个方面进行研发。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前投资。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>这篇文章由 Simply Wall St 撰写，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，采用无偏见的方法，我们的文章并不构成财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
</div>

市值超过 100 万美元的中东低价股